JP2010523081A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523081A5
JP2010523081A5 JP2010500520A JP2010500520A JP2010523081A5 JP 2010523081 A5 JP2010523081 A5 JP 2010523081A5 JP 2010500520 A JP2010500520 A JP 2010500520A JP 2010500520 A JP2010500520 A JP 2010500520A JP 2010523081 A5 JP2010523081 A5 JP 2010523081A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
acid sequence
cdca8
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010500520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523081A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2008/056657 external-priority patent/WO2008120812A1/en
Publication of JP2010523081A publication Critical patent/JP2010523081A/ja
Publication of JP2010523081A5 publication Critical patent/JP2010523081A5/ja
Withdrawn legal-status Critical Current

Links

JP2010500520A 2007-03-30 2008-03-27 Ｃｄｃａ８−ａｕｒｋｂ複合体を標的とするスクリーニング方法およびｎｓｃｌｃの治療方法 Withdrawn JP2010523081A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90934707P 2007-03-30 2007-03-30
PCT/JP2008/056657 WO2008120812A1 (en) 2007-03-30 2008-03-27 Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex

Publications (2)

Publication Number Publication Date
JP2010523081A JP2010523081A (ja) 2010-07-15
JP2010523081A5 true JP2010523081A5 (https=) 2011-05-12

Family

ID=39808392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010500520A Withdrawn JP2010523081A (ja) 2007-03-30 2008-03-27 Ｃｄｃａ８−ａｕｒｋｂ複合体を標的とするスクリーニング方法およびｎｓｃｌｃの治療方法

Country Status (4)

Country Link
US (1) US20100184047A1 (https=)
EP (1) EP2142648A4 (https=)
JP (1) JP2010523081A (https=)
WO (1) WO2008120812A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012034942A1 (en) 2010-09-13 2012-03-22 Santaris Pharma A/S Compounds for the modulation of aurora kinase b expression
US10738324B2 (en) * 2010-09-30 2020-08-11 Kagoshima University Growth-regulated viral vector containing the aurora kinase promoter
WO2012066092A1 (en) 2010-11-19 2012-05-24 Santaris Pharma A/S Compounds for the modulation of aurora kinase a expression
WO2012173846A2 (en) * 2011-06-06 2012-12-20 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN112007161B (zh) * 2020-09-17 2022-10-21 山东大学齐鲁医院 Cdca8在制备治疗卵巢癌药物中的应用
US20250127814A1 (en) * 2021-10-06 2025-04-24 The University Of Chicago Borealin targeting polypeptides for detection and treatment of cancer
CN119986009A (zh) * 2025-03-03 2025-05-13 西南医科大学附属医院 Aurkb在筛选治疗支气管肺发育不良的药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200533376A (en) * 2004-03-24 2005-10-16 Oncotherapy Science Inc Compositions and methods for treating lung cancer
JP4874234B2 (ja) * 2004-08-10 2012-02-15 オンコセラピー・サイエンス株式会社 非小細胞肺癌関連遺伝子ＡＮＬＮ、およびそのＲｈｏＡとの相互作用
EP1799854B1 (en) * 2004-09-24 2010-09-01 Oncotherapy Science, Inc. METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
EP1915622A2 (en) * 2005-07-29 2008-04-30 Oncotherapy Science, Inc. Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex

Similar Documents

Publication Publication Date Title
RU2010111120A (ru) Eb13, dlx5, nptx1 и cdkn3 в качестве генов-мишеней для терапии и диагностики рака легкого
US10705087B2 (en) Detection method for NTRK3 fusion
JP2010523081A5 (https=)
JP2012135301A5 (https=)
JP2010500003A5 (https=)
JP2010512730A5 (https=)
JP2012501164A5 (https=)
JP2010512730A (ja) 肺癌の腫瘍マーカーおよび治療標的としてのｔｔｋ
US8975086B2 (en) Method for treating or preventing bladder cancer using the DEPDC1 polypeptide
JP2012501165A5 (https=)
JP2010523081A (ja) Ｃｄｃａ８−ａｕｒｋｂ複合体を標的とするスクリーニング方法およびｎｓｃｌｃの治療方法
Neusiedler et al. INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation
US20210292853A1 (en) Detection of cldn18-arhgap6 fusion gene or cldn18-arhgap26 fusion gene in pancreatic cancer
JP5150855B2 (ja) Ｃｄｃａ１−ｋｎｔｃ２複合体を標的とするスクリーニングおよびｎｓｃｌｃの治療方法
US20110014615A1 (en) METHOD FOR DIAGNOSING NON-SMALL CELL LUNG CANCERS BY tRNA-DIHYDROURIDINE SYNTHASE ACTIVITY OF URLC8
JP2009505633A5 (https=)
RU2011111551A (ru) C12orf48 как ген-мишень для лечения и диагностики рака
JP2014523736A5 (https=)
RU2011111532A (ru) Твс1d7 в качестве опухолевого маркера и терапевтической мишени в случае злокачественной опухоли
JP2009502732A5 (https=)
JP2010501162A (ja) 肺癌の治療標的及び予後指標としてのｉｍｐ−１癌遺伝子
WO2012023290A1 (en) Rasef as tumor marker and therapeutic target for cancer
RU2010141742A (ru) С2оrf18 В КАЧЕСТВЕ ГЕНА-МИШЕНИ ДЛЯ ТЕРАПИИ И ДИАГНОСТИКИ РАКА
KR101469849B1 (ko) 마이크로ｒｎａ 활성 측정 방법
Yerramilli et al. The breast cancer susceptibility gene product (γ-synuclein) alters cell behavior through it interaction with phospholipase Cβ